Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer.
OBJECTIVE
Black patients undergo potentially curative surgery for early-stage lung cancer at a lower rate when compared with white patients. Our study examines the relationship between the percentage of black patients treated at a hospital to determine whether it affects the likelihood of obtaining cancer-directed surgery for patients with non-small-cell lung cancer (NSCLC).


METHODS
We examined claims data of Medicare-eligible patients with nonmetastatic NSCLC living in areas monitored by the Surveillance, Epidemiology, and End Results program between 1991 and 2001. Hospitals were categorized by the percentage of black patients seen: <or= 8%, more than 8% to 29%, and >or= 30%. Logistic regression with clustering analysis was used to calculate the odds of undergoing surgical resection.


RESULTS
Among 9,688 patients with NSCLC, 59% of white patients were seen at a hospital that had <or= 8% black patients, whereas 60% of black patients were seen in hospitals that had >or= 30% black patients. Regression analysis revealed that hospital racial composition of 30% or greater black patients had a significant negative effect on the likelihood of undergoing surgery for all patients (odds ratio [OR] = 0.71; 95% CI, 0.57 to 0.87), with black race (OR = 0.69; 95% CI, 0.56 to 0.85) and being seen at a low-volume hospital (OR = 0.64; 95% CI, 0.0.49 to 0.83) having a significant negative impact on likelihood of undergoing surgery.


CONCLUSIONS
Our study results indicate that patient and hospital characteristics are significant predictors of undergoing surgery for Medicare beneficiaries with localized lung cancer. Further examination of the role of the patient-, provider-, and hospital-level factors, in association with the decision to pursue surgical treatment of localized lung cancers, is needed.
Lathan
Christopher S
CS
Department of Medical Oncology, Division of Population Sciences, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA 02115, USA. christopher_lathan@dfci.harvard.edu
Neville
Bridget A
BA
Earle
Craig C
CC
D000368:Aged; D044383:Black People; D002289:Carcinoma, Non-Small-Cell Lung / Q000208:ethnology / Q000601:surgery*; D005260:Female; D006761:Hospitals / Q000706:statistics & numerical data*; D006801:Humans; D008175:Lung Neoplasms / Q000208:ethnology / Q000601:surgery*; D008297:Male; D011013:Pneumonectomy / Q000706:statistics & numerical data*; D018426:SEER Program; D014481:United States; D044465:White People; D001741:Black or African American
N Engl J Med. 2001 Jul 19;345(3):181-8
11463014
Med Care. 2007 Jul;45(7):655-63
17571014
Med Care. 1993 Aug;31(8):732-48
8336512
J Clin Epidemiol. 1992 Jun;45(6):613-9
1607900
N Engl J Med. 2005 Aug 18;353(7):683-91
16107621
Med Care. 2005 Apr;43(4):308-19
15778634
Soc Sci Med. 1985;20(4):371-9
3992281
Chest. 2000 May;117(5):1239-46
10807806
N Engl J Med. 2004 Aug 5;351(6):575-84
15295050
Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):25-31
16434582
Ann Intern Med. 2003 Oct 7;139(7):558-63
14530226
J Clin Epidemiol. 1997 Aug;50(8):939-45
9291879
N Engl J Med. 1999 Oct 14;341(16):1198-205
10519898
Cancer Causes Control. 2005 Feb;16(1):71-4
15750860
J Clin Oncol. 2006 Jan 20;24(3):413-8
16365180
Med Care. 2005 Apr;43(4):320-9
15778635
Am J Public Health. 1992 May;82(5):703-10
1566949
J Am Coll Cardiol. 2006 Jan 17;47(2):417-24
16412871
J Clin Oncol. 2002 Apr 1;20(7):1786-92
11919235
J Thorac Cardiovasc Surg. 2002 Jun;123(6):1173-6
12063465
Semin Surg Oncol. 2003;21(2):74-84
14508857
J Chronic Dis. 1987;40(5):373-83
3558716
Ann Surg. 2005 Jan;241(1):179-84
15622006
Circulation. 2005 Oct 25;112(17):2634-41
16246963
Cancer. 2001 Jun 15;91(12):2476-82
11413540
J Clin Epidemiol. 2000 Dec;53(12):1258-67
11146273
Laryngoscope. 2006 Aug;116(8):1473-7
16885756
Cancer. 1995 Dec 1;76(11):2343-50
8635041
Ann Surg. 2006 Feb;243(2):281-6
16432363
Clin Infect Dis. 2003 Dec 1;37(11):1549-55
14614679